0001209191-16-129222.txt : 20160622 0001209191-16-129222.hdr.sgml : 20160622 20160622162120 ACCESSION NUMBER: 0001209191-16-129222 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160621 FILED AS OF DATE: 20160622 DATE AS OF CHANGE: 20160622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIND Therapeutics, Inc CENTRAL INDEX KEY: 0001385228 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 325 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174913400 MAIL ADDRESS: STREET 1: 325 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: BIND Biosciences, Inc DATE OF NAME CHANGE: 20130130 FORMER COMPANY: FORMER CONFORMED NAME: BIND Biosciences Inc DATE OF NAME CHANGE: 20070105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LYNCH DANIEL CENTRAL INDEX KEY: 0001177082 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36072 FILM NUMBER: 161726794 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-21 0 0001385228 BIND Therapeutics, Inc BIND 0001177082 LYNCH DANIEL C/O BIND THERAPEUTICS, INC. 325 VASSAR STREET CAMBRIDGE MA 02139 1 0 0 1 Chairman Employee Stock Option (Right to Buy) 0.44 2016-06-21 4 A 0 20000 0.00 A 2026-06-20 Common Stock 20000 20000 D Vests and becomes exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service as a member of the Board of Directors of the Issuer through the applicable vesting date. /s/ Andrew Hirsch, Attorney-in-Fact for Daniel Lynch 2016-06-22